Maria Alonso PhD

María Jose Alonso is full professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela.She has pioneered the design and development of novel nanostructures for the targeted delivery of drugs and vaccines. She has also made critical contributions to the understanding of the interaction and transport of biodegradable nanoparticles through biological barriers, with special emphasis in mucosal barriers (intestinal, nasal, ocular).

She has been the coordinator and PI of several consortia and cooperative projects financed by the WHO, the “Bill ad Melinda Gates Foundation” and the European Commission. Currently, she is coordinating the TRANS-INT consortium (oral peptide delivery).She is the author of more than 200 international scientific contributions with more than 9000 cites (H factor 57). Because of the quality of her papers she has been among the TOP TEN in Pharmacology, according to the Times Higher Education international ranking (2011).

Alonso is a member of The Royal National Academy of Pharmacy. She is part of the scientific boards of a number of societies and she is a member of the executive board of the Controlled Release Society. She has also received 15 Awards, among them the “King Jaume I Award” given to the best researcher in the area of new technologies in Spain and the Maurice Marie Janot Award 2014 (APGI).Alonso is a member of The Royal National Academy of Pharmacy. She is part of the scientific boards of a number of societies and she is a member of the executive board of the Controlled Release Society. She has also received 15 Awards, among them the “King Jaume I Award” given to the best researcher in the area of new technologies in Spain and the Maurice Marie Janot Award 2014 (APGI).